High prevalence of hepatitis C virus infection among noninjecting drug users: Association with sharing the inhalation implements of crack

Liver International

Volumn 28, Issue 6, 2008, Pages 781-786

  Macías, Juan ^a   Palacios, Rosa B ^a   Claro, Evangelina ^b   Vargas, Julio ^a   Vergara, Salvador ^a   Mira, José A ^a   Merchante, Nicolás ^a   Corzo, Juan E ^a   Pineda, Juan A ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b Centro de Drogodependencias 'Antaris'   (Spain)

Author keywords

Crack; HCV infection; Noninjecting drug use

Indexed keywords

COCAINE; DIAMORPHINE;

ADULT; ARTICLE; BODY PIERCING; COCAINE DEPENDENCE; DRUG ABUSE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; SENESCENCE; TATTOOING; VIRUS TRANSMISSION;

ADMINISTRATION, INHALATION; ADULT; BODILY SECRETIONS; COMORBIDITY; CRACK COCAINE; CROSS-SECTIONAL STUDIES; EQUIPMENT CONTAMINATION; FEMALE; HEPACIVIRUS; HEPATITIS C; HEROIN; HUMANS; MALE; NARCOTICS; ODDS RATIO; PREVALENCE; RISK-TAKING; RNA, VIRAL; SALIVA; SEXUAL BEHAVIOR; SPAIN; SUBSTANCE-RELATED DISORDERS;

EID: 44949210418     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01688.x     Document Type: Article

References (25)

1. Alter MJ. Prevention of spread of hepatitis C. Hepatology 2002; 36: S93-8.
2. Hahn JA, Page-Shafer K, Lum PJ, et al. Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. J Infect Dis 2002; 186: 1558-64.
3. Hwang LY, Kramer JR, Troisi C, et al. Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population. Hepatology 2006; 44: 341-51.
4. Tortu S, Neaigus A, Mcmahon J, Hagen D. Hepatitis C among noninjecting drug users: A report. Subst Use Misuse 2001; 36: 523-34.
5. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-14.
6. Scheinmann R, Hagan H, Lelutiu-Weinberger C, et al. Non-injection drug use and hepatitis C virus: A systematic review. Drug Alcohol Depend 2007; 89: 1-12.
7. Conry-Cantilena C, Vanraden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691-6.
8. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-62.
9. Howe CJ, Fuller CM, Ompad DC, et al. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug Alcohol Depend 2005; 79: 389-95.
10. Gyarmathy VA, Neaigus A, Miller M, et al. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir Immune Defic Syndr 2002; 30: 448-56.
11. Roy E, Haley N, Leclerc P, et al. Risk factors for hepatitis C virus infection among street youths. Can Med Assoc J 2001; 165: 557-60.
12. Page-Shafer KA, Cahoon-Young B, Klausner JD, et al. Hepatitis C virus infection in young, low-income women: The role of sexually transmitted infection as a potential cofactor for HCV infection. Am J Public Health 2002; 92: 670-6.
13. Tortu S, Mcmahon JM, Pouget ER, Hamid R. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Subst Use Misuse 2004; 39: 211-24.
14. Murphy EL, Bryzman SM, Glynn SA, et al. Risk factors for hepatitis C virus infection in United States blood donors. Hepatology 2000; 31: 756-62.
15. Mcmahon JM, Simm M, Milano D, Clatts M. Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user. Ann Clin Microbiol Antimicrob H004; 3: 6. Available at: http://www.ann-clinmicrob.com/ content/3/1/6.
16. Hermida M, Ferreiro MC, Barral S, et al. Detection of HCV RNA in saliva of patients with hepatitis C virus infection by using a highly sensitive test. J Virol Methods 2002; 101: 29-35.
17. Anthony JC, Vlahov D, Celentano DD, et al. Self-report interview data for a study of HIV-1 infection among intravenous drug users: Description of methods and preliminary evidence of validity. J Drug Issues 1991; 81: 739-57.
18. Briggs ME, Baker C, Hall R, et al. Prevalence and risk factors for hepatitis C virus infection in a urban Veterans Administration medical center. Hepatology 2001; 34: 1200-5.
19. Thorpe LE, Ouellet LJ, Levy JR, et al. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. J Infect Dis 2000; 182: 1588-94.
20. Haley RW, Fisher RP. The tattooing paradox: Are studies of acute hepatitis adequate to identify routes of transmission of subclinical hepatitis C infection? Arch Intern Med 2003; 163: 1095-8.
21. Hahn JA, Page-Shafer K, Lum PJ, et al. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology 2001; 34: 180-7.
22. Ross MW, Hwang LY, Zack C, et al. Sexual risk behaviours and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. Int J STD AIDS 2002; 13: 769-74.
23. Hwang LY, Ross MW, Zack C, et al. Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin Infect Dis 2000; 31: 920-6.
24. Weinstock HS, Bolan G, Reingold AL, Polish LB. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA 1993; 269: 392-4.
25. Faruque S, Edlin BR, Mccoy CB, et al. Crack cocaine smoking and oral sores in three inner-city neighborhoods. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: 87-92.